Ganeden expanded distribution partnerships with a number of local companies, renewing and adding contracts with distributors.
Kerry Group has recently announced the acquistion of US probiotic ingredients manufacturer Ganeden. Ohio-based Ganeden has a revenue of around $25 million and Kerry claimed it has more than 135 patents for technologies in the supplement, food, beverage, nutrition and personal care markets.
The acquisition complements Kerry’s purchase of supplement ingredient brand Wellmune in 2015.
Ganeden had previously announced a series of new global partnerships to help the company expand its international footprint and drive growth.
The company expanded distribution partnerships with a number of local companies, renewing and adding contracts with distributors in Bangladesh, China, India, Japan, Korea, Malaysia, Singapore, Taiwan, Thailand, the Philippines and Vietnam.
Kerry expects to deliver in excess of 10 per cent adjusted earnings per share growth on average per annum over the next five year years.
